Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.
Journal: European journal of gynaecological oncology
Published: March 06, 2023
Showing 1-2 of 2
Last Updated: 09/26/2026